Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Alprostadil as an Adjuvant Therapy With Indirect Angiosomal Revascularization in Patients With Critical Limb Ischemia.

NCT04312555 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT04312555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04312555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Alprostadil as an Adjuvant Therapy With Indirect Angiosomal Revascularization in Patients With Critical Limb Ischemia.
Lead sponsor
Assiut University
Phase
Phase 4
Overall status
Unknown status
Start date
April 1, 2020
Completion date
October 1, 2021
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia